UAB Digital Repository of Documents 3 records found  Search took 0.02 seconds. 
1.
9 p, 468.5 KB Preliminary data on COVID-19 in patients with hemoglobinopathies : A multicentre ICET-A study / De Sanctis, Vincenzo (Pediatric and Adolescent Outpatient Clinic. Quisisana Hospital) ; Canatan, Duran (Antalya Genetic Diseases Diagnostic Center) ; Vives Corrons, Juan Luís (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Karimi, M. (Hematology Research Center. Shiraz University of Medical Sciences) ; Daar, S. (Department of Haematology. College of Medicine and Health Sciences. Sultan Qaboos University) ; Kattamis, C. (First Department of Paediatrics. National Kapodistrian University of Athens) ; Soliman, A. T. (Department of Pediatrics. University of Alexandria) ; Wali, Y. (Department of Paediatrics. Faculty of Medicine. Alexandria University) ; Alkindi, S. (Department of Haematology. College of Medicine and Health Sciences. Sultan Qaboos University) ; Huseynov, V. (Center of Thalassemia) ; Nasibova, A. (Center of Thalassemia) ; Tiryaki, T. O. (İstanbul University. Faculty of Medicine. Department of Hematology) ; Evim, M. S. (Uludag University. Medical Faculty. Dept. of Pediatric Hematology) ; Gunes, A. M. (Uludag University. Medical Faculty. Dept. of Pediatric Hematology) ; Karakas, Z. (Istanbul University. Istanbul Faculty of Medicine. Pediatric Hematology / Oncology) ; Christou, S. (Archibishop Makarios III Hospital. Thalassaemia Clinic) ; Campisi, S. (UOSD Thalassemia. Umberto I° Hospital) ; Zarei, T. (Hematology Research Center. Shiraz University of Medical Sciences) ; Khater, D. (Department of Pediatrics. Sultan Qaboos University) ; Oymak, Y. (Dr. Behcet Uz Children's Hospital) ; Kaleva, V. (Expert Center for Coagulopathies and Rare Anemias) ; Stoyanova, D. (Pediatric Hematoncology. University Hospital "Tzaritza Giovanna - ISUL") ; Banchev, A. (Pediatric Hematoncology. University Hospital "Tzaritza Giovanna - ISUL") ; Galati, M. C. (Pediatric Haematoncology. Pugliese-Ciaccio Hospital) ; Yassin, M. A. (Hematology Section. National Center for Cancer Care and Research. Hamad Medical Corporation. (HMC)) ; Kakar, S. (Pediatric Hematology Oncology. Department of Pediatrics. Dayanand Medical College and Hospital) ; Skafida, M. (First Department of Paediatrics. National Kapodistrian University of Athens) ; Kilinc, Y. (Pediatric Hematology Department. Çukurova University) ; Alyaarubi, S. (Pediatric Endocrinology Unit. Child Health Department. College of Medicine and Health Sciences. Sultan Qaboos University) ; Verdiyevas, N. (Center of Thalassemia) ; Stoeva, I. ("Screening and Functional Endocrine Diagnostics". University Paediatric Hospital) ; Raiola, G. (Department of Paediatrics. Pugliese-Ciaccio Hospital) ; Mariannis, D. (Royal Lancaster Infirmary) ; Ruggiero, L. (Pediatrician) ; Di Maio, S. (Emeritus Director in Pediatrics. "Santobono-Pausilipon" Children's Hospital) ; Universitat Autònoma de Barcelona
Objectives: This study aims to investigate, retrospectively, the epidemiological and clinical characteristics, laboratory results, radiologic findings, and outcomes of COVID-19 in patients with transfusion-dependent β thalassemia major (TM), β-thalassemia intermedia (TI) and sickle cell disease (SCD). [...]
2020 - 10.4084/MJHID.2020.046
Mediterranean Journal of Hematology and Infectious Diseases, Vol. 12 Núm. 1 (2020) , p. e2020046  
2.
11 p, 623.1 KB Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia / Megías-Vericat, Juan Eduardo (Hospital Universitari i Politècnic La Fe (València)) ; Martínez-Cuadrón, David (Centro de Investigación Biomédica en Red de Cáncer) ; López, Joaquín Martínez (Hospital Universitario 12 de Octubre (Madrid)) ; Bergua Burgues, Juan Miguel (Hospital San Pedro de Alcántara) ; Tormo, Mar (Hospital Clínic Universitari (València)) ; Serrano, Josefina (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; González, Ataulfo (Hospital Clínico San Carlos (Madrid)) ; Perez de Oteyza, Jaime (Hospital Universitario HM Sanchinarro (Madrid)) ; Vives Polo, Susana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Vidriales, Belén (Complejo Asistencial Universitario de Salamanca) ; Herrera, Pilar (Hospital Universitario Ramon y Cajal (Madrid)) ; Vera, Juan Antonio (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Martínez, Aurelio López (Hospital Arnau de Vilanova (Lleida, Catalunya)) ; De La Fuente, Adolfo (MD Anderson Cancer Center, Madrid, Spain) ; Amador, Ma Lourdes (Hospital Montecelo de Pontevedra) ; Hernández-Rivas, José-Ángel (Hospital Universitario Infanta Leonor) ; Fernández, Ma Ángeles (Hospital Xeral-Cíes (Vigo, Galícia)) ; Cervero, Carlos (Hospital Virgen de La Luz (Cuenca)) ; Morillo, Daniel (Hospital Universitario Fundación Jiménez Díaz) ; Campo, Pilar Hernández (Vivia Biotech, Tres Cantos, Madrid, Spain) ; Gorrochategui, Julián (Vivia Biotech, Tres Cantos, Madrid, Spain) ; Primo, Daniel (Vivia Biotech, Tres Cantos, Madrid, Spain) ; Rojas, José Luis (Vivia Biotech, Tres Cantos, Madrid, Spain) ; Guenova, Margarita (Specialized Hospital for Active Treatment of Hematological Diseases, Sofía, Bulgaria) ; Ballesteros, Joan (Vivia Biotech, Tres Cantos, Madrid, Spain) ; Sanz, Miguel A. (Centro de Investigación Biomédica en Red de Cáncer) ; Montesinos, Pau (Centro de Investigación Biomédica en Red de Cáncer) ; Universitat Autònoma de Barcelona
Induction schedules in acute myeloid leukemia (AML) are based on combinations of cytarabine and anthracyclines. The choice of the anthracycline employed has been widely studied in multiple clinical trials showing similar complete remission rates. [...]
2019 - 10.4084/MJHID.2019.016
Mediterranean Journal of Hematology and Infectious Diseases, Vol. 11 (march 2019)  
3.
9 p, 316.0 KB Treatment of Adolescent and Young Adults with Acute Lymphoblastic Leukemia / Ribera, Jose-Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ribera Salas, Jordi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Genescà, Eulàlia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
The primary objective of this review was to update and discuss the current concepts and the results of the treatment of acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYA). After a brief consideration of the epidemiologic and clinicobiologic characteristics of ALL in the AYA population, the main retrospective comparative studies stating the superiority of pediatric over adult-based protocols were reviewed. [...]
2014 - 10.4084/MJHID.2014.052
Mediterranean Journal of Hematology and Infectious Diseases, Vol. 6 (july 2014)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.